anti-TL1A monoclonal antibody, medium dose

BIOLOGICAL2 trials

Sponsors

Biocad

Conditions

Crohn's Disease (CD)Ulcerative Colitis (UC)

Phase 2

Clinical Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Crohn's Disease

RecruitingNCT07078994

BiocadCrohn's Disease (CD)

Start: 2025-08-14End: 2029-01-31Target: 204Updated: 2025-09-17

Study of the Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of BCD-261 in Subjects With Moderate to Severe Active Ulcerative Colitis

RecruitingNCT07080034

BiocadUlcerative Colitis (UC)

Start: 2025-08-14End: 2028-10-31Target: 198Updated: 2025-09-19